Biannual Pharmacometrics Network Benelux (PNB) meeting Conference Biannual Pharmacometrics Network Benelux (PNB) meeting CertaraNovember 20, 2024
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women Publication Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…CertaraNovember 18, 2024
Predicting Disease Activity Scores in Inflammatory Bowel Disease (IBD) Poster Predicting Disease Activity Scores in Inflammatory Bowel Disease (IBD) Disease activity scores in IBD are widely used for measuring disease severity and therapeutic outcomes.…CertaraNovember 14, 2024
Mastering Value Storytelling with Data-Driven Stories Blog Mastering Value Storytelling with Data-Driven Stories Unlocking the Power of Storytelling in Healthcare Communication In the realm of healthcare communication, persuasion…CertaraNovember 14, 2024
Streamline Regulatory Writing with AI-Powered Solutions White Paper Streamline Regulatory Writing with AI-Powered Solutions Learn how tailored AI solutions streamline regulatory writing, boosting efficiency, accuracy, & compliance.CertaraNovember 14, 2024
Quantitative Systems Pharmacology Model for Therapies Targeting Aβ and tau Pathologies in Alzheimer’s Disease Poster Quantitative Systems Pharmacology Model for Therapies Targeting Aβ and tau Pathologies in Alzheimer’s Disease CertaraNovember 14, 2024
Model-Informed Drug Development (MIDD) to Accelerate ADC Development and Maximize Therapeutic Index Poster Model-Informed Drug Development (MIDD) to Accelerate ADC Development and Maximize Therapeutic Index CertaraNovember 14, 2024
Enhancing Pharmacokinetics Workflows at Charles River Case Study Enhancing Pharmacokinetics Workflows at Charles River PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…CertaraNovember 13, 2024
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation Publication ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation Abstract Immune checkpoint inhibitors (ICI) have transformed cancer treatment. However, only a minority of patients…CertaraNovember 13, 2024
PBPK Modeling to Support Bioequivalence & Generic Product Approvals Blog PBPK Modeling to Support Bioequivalence & Generic Product Approvals Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…CertaraNovember 12, 2024